Skip to content

SGS Lab Simon

Active
Public limited companyfounded 1971active for 54 yearsVieux Chemin du Poète 10, 1301 Wavre, BelgiumKBO/BCE: BE 0411.881.794
Summary

SGS Lab Simon has been active since 1971 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €1.6m. Equity remains stable across the filed financial years (±0.6% per year). Its solvency ranks better than 15% of 778 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910Other technical testing and analysis NACE 71209
Largest employer in Wavre, Health and social work sector2 sites
Size
€25.8mturnover 2025
Staff
177.9 FTE
Equity
€1.2m
Profit
€1.6m
Financial health
83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
SGS BELGIUM · 100%
Accounts filed 35 days late2 of 27 deeds read
Why 83raises riskLiquidity: current ratio 0.69, cash €206,549Equity €1.2m (9.5% of total assets)Latest accounts 35 days late; 1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 29% of its sector peers (NACE 86, medium-sized)
Financial strength · tick = 2024
Weak
Solvency 34-1
equity 9.5% of total assets
Liquidity 2-2
short-term debt 90.4% · cash 1.6%
Profitability 79+1
return on assets 12.5%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (83 companies, NACE 86, medium-sized)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.3%▲ +0.1 percentage points vs 09-2026highest value
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.69, compared with 0.64 in 2024, below 1; short-term debt: 90.4% and cash: 1.6% of total assets), and 90.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized): better than 11% on solvency, 3% on liquidity, 73% on profitability and 31% on growth.

The bankruptcy probability was computed on 17-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.69, cash €206,549
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Equity €1.2m (9.5% of total assets)
NBB · annual accounts
raises risk · Latest accounts 35 days late; 1 of the last 3 late
NBB · filings
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 778 sector peers (2025).
NBB · sector comparison
Position among 778 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · A punctual record breaks
This company filed 9 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-09-2026, 35 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
35 days late
2024
23 days early
2023
23 days early
2022
21 days early
2021
16 days early
2020
23 days early
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
18-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Permanent representatives: Anke Verrijssen and Filip…Power of attorney
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Positive: Largest employer in Wavre, Health and social work sectorin the Checked rankings No. 1 View
  • Positive: 8 profitable years in a rowprofit 2025: €1.6m 8 years View
  • Controlled by SGS BELGIUM 100% View
  • Active since 1971founded 26-11-1971 54 years View

By topic

Financials

Financial year
2025
Turnover
€25.8m
Profit
€1.6m
Solvency
9.5%
Turnover▼ 0.7%
Net result
20182025
Go to Financials

Timeline

Events
53
Since
1978
Next accounts
by 31-07-2027
  1. 24-07-2024Reappointments: Johan Pype, Kristof Van den Elsen…
  2. 08-07-2024Annual accounts filed
  3. 31-12-2023Weakest financial year
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
26-11-1971
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.